Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06255288
Other study ID # F-23054461
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 23, 2024
Est. completion date December 31, 2024

Study information

Verified date February 2024
Source Hvidovre University Hospital
Contact Pia Søe Jensen, PhD
Phone +45 3862 2464
Email pjen0002@regionh.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to examine the feasibility, acceptability, fidelity, and outcome of a nurse-led nutritional intervention for patients with leg ulcers in a outpatient clinics. The intervention consists of a structured dialogue and patient information on key lifestyle behaviours to improve wound healing. Furthermore, the intervention includes protein supplement.


Description:

The study aims to address the following research questions: Primary Research Questions: 1. Is the patient recruitment process feasible? 2. Is the delivery of the intervention feasible? 3. Is the intervention acceptable to the patients? 4. Is the intervention acceptable to the nurses? 5. Is the intervention consistently maintained during the study period? 6. Are the data collection procedures feasible? 7. Are the outcome measures feasible? 8. What are the reasons for any dropouts? Secondary Research Questions: 1. What are the patients' and relatives' views on receiving the intervention? 2. Are there any longitudinal differences in outcomes for the patient group? 3. Are there any individual patient-specific differences in outcomes over time? The feasibility study will recruit patients with a first-time referral to the outpatient clinic at the Department of Orthopaedic Surgery at Copenhagen University Hospital, Hvidovre, for leg ulcers caused by arterial or venous disease or neuropathy due to diabetes. The intervention will be administered by the clinic's nurses. After inclusion, each patient will be contacted by telephone following their next two clinic visits. The initial follow-up will assess patient characteristics, information about their wound using the Wound-Qol Questionnaire, and their perspective on receiving the intervention. The second and final follow-up will consist of an interview exploring their perspective on receiving the intervention. Additionally, focus group interviews with the nurses will be conducted to investigate their capability, opportunity, and motivation (COM-B model) for implementing the intervention. Both patient and nurse interviews will be recorded and transcribed.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 31, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with leg ulcers caused by arterial or venous disease or neuropathy caused by diabetes. - Patient with an amputation wound. - Speak and understand Danish. Exclusion Criteria: - Patients with wounds caused by high-intensity trauma. - Patients in the end-of-life phase. - Patients living in nursing homes. - Patients with cognitive impairment.

Study Design


Intervention

Other:
SNAK intervention
The intervention consists of structured dialogue, patient information, and a protein supplement. The structured dialogue part of the intervention consists of an A3 poster with illustrations and keywords which will be hanging in the outpatient clinics. The poster will be utilized by nurses, patients, and their relatives to facilitate a dialogue regarding nutrition and wound healing. The patient information part of the intervention consists of a leaflet with easy-to-read information, which patients and their relatives can bring home after their visit to the outpatient clinic. The leaflet will consist of general information as well as food categories and recipes they can use to enhance their daily protein intake. For the protein supplement part of the intervention, the patients will have access to protein supplement beverages while they are in the outpatient clinic waiting room. Furthermore, they will receive prescriptions for protein drinks, that they can pick up at their local pharmacy.

Locations

Country Name City State
Denmark Outpatient clinic at the Department of Orthopedic Surgery, Hvidovre University Hospital Copenhagen

Sponsors (2)

Lead Sponsor Collaborator
Hvidovre University Hospital Roskilde University

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary SNAK Feasibility questionnaire (SFQ) - Element 1: Evaluating structured dialogue The intervention is deemed non-feasible if, during their visit to the outpatient clinic, fewer than 80% of the patients:
Noticed the dialogue tool.
Had a conversation with the nurses about nutrition and wound healing using the dialogue tool.
Found the conversation with the nurses about nutrition and wound healing relevant and valuable.
Considered it acceptable to have a conversation with the nurses about nutrition and wound healing.
The SFQ has two scoring systems: 1) Binary scores (yes/no) with a non-applicable option as well and 2) categorical 5-point score (1 is the highest score and 5 is the lowest score in regards to agreement on statements related to the interventions feasibility). The 5-point categorical score will be presented with median and interquartile ranges (IQR).
Measurements will be taken within 1 week after their second and third visits to the outpatient clinic. Each patient will be followed up to maximum 16 weeks after inclusion.
Primary SNAK Feasibility questionnaire (SFQ) - Element 2: Evaluating patient and relative information The intervention is considered non-feasible if, during their visit to the outpatient clinic, fewer than 80% of the patients:
Received a leaflet.
Could read and understand the leaflet.
Found the information in the leaflet relevant.
have attempted to use the suggested recipes or food categories.
have attempted to change their diet.
The SFQ has two scoring systems: 1) Binary scores (yes/no) with a non-applicable option as well and 2) categorical 5-point score (1 is the highest score and 5 is the lowest score in regards to agreement on statements related to the interventions feasibility). The 5-point categorical score will be presented with median and interquartile ranges (IQR).
Measurements will be taken within 1 week after their second and third visits to the outpatient clinic. Each patient will be followed up to maximum 16 weeks after inclusion.
Primary SNAK Feasibility questionnaire (SFQ) - Element 3: Evaluating protein supplement The intervention is considered non-feasible if, during their visit to the outpatient clinic, fewer than 80% of the patients:
Were offered a protein supplement drink.
Were offered a prescription for protein supplement drinks.
Agree that patients should be offered a protein supplement drink.
The SFQ has two scoring systems: 1) Binary scores (yes/no) with a non-applicable option as well and 2) categorical 5-point score (1 is the highest score and 5 is the lowest score in regards to agreement on statements related to the interventions feasibility). The 5-point categorical score will be presented with median and interquartile ranges (IQR).
Measurements will be taken within 1 week after their second and third visits to the outpatient clinic. Each patient will be followed up to maximum 16 weeks after inclusion.
Primary SNAK Feasibility questionnaire (SFQ) - Element 4: Evaluating overall intervention The intervention is considered non-feasible if fewer than 80% of the patients, during their visit to the outpatient clinic, are confident that they can follow the advice regarding nutrition and lifestyle in their daily lives.
The SFQ has two scoring systems: 1) Binary scores (yes/no) with a non-applicable option as well and 2) categorical 5-point score (1 is the highest score and 5 is the lowest score in regards to agreement on statements related to the interventions feasibility). The 5-point categorical score will be presented with median and interquartile ranges (IQR).
Measurements will be taken within 1 week after their second and third visits to the outpatient clinic. Each patient will be followed up to maximum 16 weeks after inclusion.
Primary Qualitative evaluation of nurses' Capability, Opportunity, and Motivation (COM-B) to implement the intervention. COM-B will be explored using a semi-structured focus group interview with the nurses and will be carried out in the outpatient clinic following the end of inclusion (16 weeks after first inclusion). Measured 16 weeks after first inclusion.
Primary Procedural uncertainties - Number of patients willing to participate. Following criteria are considered to evaluate the recruitment of participation in the intervention.
If less than 30% are willing to participate in the intervention, then the intervention is considered non-feasible.
If recruitment falls within the range of 30 to 80% modification will be considered.
If 80% or more are recruited, the study is deemed feasible without modification.
Measured 4, 8, 12, and 16 weeks after first inclusion.
Secondary Recruitment rates The number of eligible patients that agree to participate will be collected. Every week until study completion (16 weeks after first inclusion).
Secondary Drop out rates The number of included patients that withdraw consent or drop out for other reasons will be collected. Furthermore, we will collect reasons for dropout. Every week until study completion (16 weeks after first inclusion).
See also
  Status Clinical Trial Phase
Completed NCT03903692 - A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers N/A
Completed NCT03257254 - Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)
Recruiting NCT03666754 - Early Glue Saphenous Vein Ablation With Compression Versus Compression Alone in the Healing of the Venous Ulcer N/A
Withdrawn NCT02912858 - Intermittent Pneumatic Compression of the Foot vs Geko Plus R-2 Neuromuscular Electrostimulation Device in Venous Leg Ulcer Patients N/A
Completed NCT02482038 - Geko Venous Leg Ulcer Study N/A
Completed NCT02652572 - Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers Phase 1
Unknown status NCT01658618 - Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer N/A
Completed NCT05646121 - Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
Completed NCT03077165 - Dose-response Relationship Study of S42909 on Leg Ulcer Healing Phase 2
Completed NCT04461132 - The Effect of Manual Lymphatic Drainage N/A
Completed NCT05974982 - Treatment Outcome of Autologous PRP Versus Conventional Therapy Among Patients With Chronic Venous Leg Ulcers Phase 1
Completed NCT04011371 - Cyanoacrylate Closure for Treatment of Venous Leg Ulcers N/A
Not yet recruiting NCT03543007 - Evaluating the Safety and Efficacy of GrafixPLâ„¢PRIME for the Treatment of Chronic Venous Leg Ulcers N/A
Completed NCT03286140 - Early Venous Reflux Ablation Ulcer Trial N/A
Recruiting NCT05588583 - A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing. N/A
Not yet recruiting NCT04613687 - Efficacy and Safety of a New Compression System URGO BD001 in the Treatment of VLU (FREEDOM) N/A
Recruiting NCT05549609 - A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers Phase 1/Phase 2
Recruiting NCT05409976 - The GORE® VIAFORT Vascular Stent IVC Study N/A
Not yet recruiting NCT05089890 - Clinical Investigation of Sorbact® Dressings N/A
Not yet recruiting NCT03670329 - Management of Infection Risk in Non-comparative Trial (MINT) N/A